Darbary, Niloofer2021-10-282021-10-282021-01-06https://hdl.handle.net/10929/74527In this interview, Participant 224 shares about their experience living with the G6PD genetic deficiency, and concerns about risks that individuals with G6PD deficiency may face during the COVID-19 pandemic. The participant describes their work as part of a global taskforce to raise awareness, coordinate advocacy efforts, and share information about G6PD deficiency. They share about concerns related to treatments and COVID-19 vaccines, and the importance of newborn testing for G6PD deficiency and studying any potential adverse reactions related to COVID-19 treatment for individuals with the deficiency.0:42:07MPEG-4en-USThis Item is protected by copyright and/or related rights. You are free to use this Item in any way that is permitted by the copyright and related rights legislation that applies to your use. In addition, no permission is required from the rights-holder(s) for non-commercial uses. For other uses you need to obtain permission from the rights-holder: New Jersey YMCA State AllianceClinical CareCOVID-19 Health BehaviorsInfant_Child HealthAccess to CareUnpredictabilityPositive OutlookView of NJ Government's Response to the PandemicHealth BehaviorsVaccine for COVID-19View of the Federal Government's Response (in 2020)Negative Mental Health OutcomesSocial Re-ConnectResources NeededIndividuals with High-Risk Health ConditionsMercer Co. (N.J.)New JerseyCOVID-19 PandemicVideoNew Jersey YMCA State Alliance